Bulgarien - Bulgarisch - БАБХ (Българска агенция по безопасност на храните)

eurovet animal health b.v. - Левотироксин натрий - таблетка - 800 microg/таблетка - кучета

Bulgarien - Bulgarisch - БАБХ (Българска агенция по безопасност на храните)

le vet beheer b.v. - levothroxine натрий - таблетки - 200 µg/таблетка - котки, кучета

Bulgarien - Bulgarisch - БАБХ (Българска агенция по безопасност на храните)

le vet beheer b.v. - levothroxine натрий - таблетка - 600 µg/таблетка - котки, кучета

Europäische Union - Bulgarisch - EMA (European Medicines Agency)

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - Антинеопластични средства - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.

Bulgarien - Bulgarisch - БАБХ (Българска агенция по безопасност на храните)

vet-agro multi-trade company sp. z o.o. - Левотироксин натрий - таблетка - 200 µg/таблетка - кучета

Bulgarien - Bulgarisch - БАБХ (Българска агенция по безопасност на храните)

vet-agro multi-trade company sp. z o.o. - Левотироксин натрий - таблетки - 400 µg/таблетки - кучета

Bulgarien - Bulgarisch - БАБХ (Българска агенция по безопасност на храните)

vet-agro multi-trade company sp. z o.o. - Левотироксин натрий - таблетка - 800 µg/таблетка - кучета

Europäische Union - Bulgarisch - EMA (European Medicines Agency)

amgen europe bv - sotorasib - Карцином, недребноклетъчен белодроб - Антинеопластични средства - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.

Europäische Union - Bulgarisch - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - mavacamten - cardiomyopathy, hypertrophic - Други сърдечни препарати - treatment of symptomatic obstructive hypertrophic cardiomyopathy.

Europäische Union - Bulgarisch - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - quizartinib dihydrochloride - Левкемия, миелоид - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.